Cerebyx Injection, Solution
Product Images NDC 0069-6001

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cerebyx (NDC 0069-6001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cerebyx 01)

Chemical structure diagram of fosphenytoin sodium, the active ingredient in CEREBYX injection. The structure shows the molecular arrangement including sodium ions, phosphate group, and phenyl rings.*

FDA Label Image

Figure 1 (Cerebyx 02)

A pharmacokinetic curve showing plasma unbound phenytoin concentration (µg/mL) over time (hours) after the start of infusion of CEREBYX (Fosphenytoin Sodium injection). The main graph covers 0 to 2 hours, with an inset graph extending to 96 hours post-infusion. Multiple data series are plotted, illustrating concentration changes during and after infusion.*

FDA Label Image

Logo (Cerebyx 03)

The label features the Pfizer logo followed by the word 'Injectables.' It states the product is distributed by Pfizer Inc, Division of Pfizer Inc, New York, NY 10017. No specific product name, strength, or dosage form information is visible in the image.*

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Label for Cerebyx (fosphenytoin sodium) Injection 500 mg PE/10 mL (50 mg PE/mL) in a 10 mL single-dose vial. The label states NDC 0069-6001-10 and indicates storage under refrigeration at 26C to 86C (366F to 466F). It includes dosage and use instructions referencing the package insert, notes on administration differences from parenteral phenytoin, and is distributed by Pfizer Laboratories, Division of Pfizer Inc, New York, NY.*

FDA Label Image

Principal Display Panel (10 mL Vial Package)

Packaging label for Cerebyx (fosphenytoin sodium) Injection 500 mg PE/10 mL (50 mg PE/mL), an injection solution for intramuscular or intravenous use. The label indicates the product is distributed by Pfizer Labs, Division of Pfizer Inc, and includes details for 10 single-dose vials of 10 mL each. The label also features storage instructions and product composition information.*

FDA Label Image

Principal Display Panel (2 mL Vial Label)

Label for Cerebyx (fosphenytoin sodium) Injection, 100 mg PE per 2 mL (50 mg PE/mL), single-dose vial for intramuscular or intravenous use. Distributed by Pfizer Laboratories Division, Pfizer Inc, NY. The label states dosage equivalence and instructs to see package insert for use instructions.*

FDA Label Image

Principal Display Panel (2 mL Vial Carton)

Packaging label for Cerebyx (fosphenytoin sodium) Injection, 100 mg PE/2 mL (50 mg PE/mL) solution for injection. The label indicates 25 single-dose vials of 2 mL each. The product is for intramuscular or intravenous use and is distributed by Pfizer Labs, Division of Pfizer Inc. The label specifies this as a prescription injectable drug by Pfizer.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.